ECSP982780A - NEW PHARMACEUTICAL PRODUCT PROCESS FOR ITS PREPARATION AND USE IN MEDICINE - Google Patents
NEW PHARMACEUTICAL PRODUCT PROCESS FOR ITS PREPARATION AND USE IN MEDICINEInfo
- Publication number
- ECSP982780A ECSP982780A ECSP982780A ECSP982780A EC SP982780 A ECSP982780 A EC SP982780A EC SP982780 A ECSP982780 A EC SP982780A EC SP982780 A ECSP982780 A EC SP982780A
- Authority
- EC
- Ecuador
- Prior art keywords
- provides
- compound
- medicine
- preparation
- presented
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Un hidrato de la sal de ácido maléico de 5-(4-(2-(N-metil-N-(2-piridil)amino etoxi)bencil) tiazolidina-2,4-diona caracterizado porque: (i) comprende agua en el intervalo de 0,4 a 2,5% p/p; y (ii) proporciona un espectro infrarrojo que contiene picos a 1749, 1703, 1645, 1623, 1365, y 736 cm-1 y/o (iii) proporciona un modelo de difracción de rayos X en polvo (XRPD) sustancialmente como se presenta en la figura II y/o proporciona un espectro Ramán que contiene picos a 3106, 3069, 3002, 2961, 1750, 1718, 1684, 1385, 1335, 1229, 1078, 917, 428, y 349 cm-1 y/o (iv) (v) proporciona un espectro de resonancia magnética nuclear en estado sólido que contiene desplazamiento químicos sustancialmente como los presentados en la tabla I; un proceso para la preparación de tal compuesto, una composición farmacéutica que contiene tal compuesto y el uso de tal compuesto o composición en medicina.A hydrate of the maleic acid salt of 5- (4- (2- (N-methyl-N- (2-pyridyl) amino ethoxy) benzyl) thiazolidine-2,4-dione characterized in that: (i) comprises water in the range of 0.4 to 2.5% w / w; and (ii) provides an infrared spectrum containing peaks at 1749, 1703, 1645, 1623, 1365, and 736 cm-1 and / or (iii) provides a X-ray powder diffraction pattern (XRPD) substantially as presented in Figure II and / or provides a peak-containing Raman spectrum at 3106, 3069, 3002, 2961, 1750, 1718, 1684, 1385, 1335, 1229, 1078, 917, 428, and 349 cm-1 and / or (iv) (v) provides a solid state nuclear magnetic resonance spectrum containing chemical shifts substantially as presented in Table I; a process for the preparation of such compound, a pharmaceutical composition containing such compound and the use of such compound or composition in medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982780 ECSP982780A (en) | 1998-12-15 | 1998-12-15 | NEW PHARMACEUTICAL PRODUCT PROCESS FOR ITS PREPARATION AND USE IN MEDICINE |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982780 ECSP982780A (en) | 1998-12-15 | 1998-12-15 | NEW PHARMACEUTICAL PRODUCT PROCESS FOR ITS PREPARATION AND USE IN MEDICINE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP982780A true ECSP982780A (en) | 1999-05-17 |
Family
ID=42043699
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP982780 ECSP982780A (en) | 1998-12-15 | 1998-12-15 | NEW PHARMACEUTICAL PRODUCT PROCESS FOR ITS PREPARATION AND USE IN MEDICINE |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP982780A (en) |
-
1998
- 1998-12-15 EC ECSP982780 patent/ECSP982780A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO4990943A1 (en) | NEW PHARMACEUTICAL PRODUCT -N- (2-PIRIDIL) AMINO) ETOXI] BENCIL] TIAZOLIDIN-2-4-DIONA | |
| AR023564A1 (en) | A POLYMORPHIC FORM OF SALT OF THE MALEIC ACID DERIVED FROM TIAZOLIDINE-2,4 DIONA, A PHARMACEUTICAL COMPOSITION AND THE USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT | |
| UY26121A1 (en) | NEW PHARMACEUTICAL COMPOUND | |
| AR017214A1 (en) | A PROCESS TO PREPARE A MALEIC ACID SALT HYDRATE OF 5- [4 [2- (N-METHYL-N- (2-PIRIDIL) AMINO) -ETOXI] BENCIL] TIAZOLIDIN-2,4-DIONA | |
| AR017430A1 (en) | A HYDRATION OF THE SALT OF THE MALEIC ACID OF THE 5 [4- [2- (N-METHYL-N- (2-PIRIDIL) AMINO) ETOXI] BENCIL] TIAZOLIDIN-2,4-DIONA, A PROCESS FOR ITS PREPARATION, COMPOSITION PHARMACEUTICAL CONTAINING AND USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT | |
| UY26119A1 (en) | NEW PHARMACEUTICAL PRODUCT | |
| ECSP982780A (en) | NEW PHARMACEUTICAL PRODUCT PROCESS FOR ITS PREPARATION AND USE IN MEDICINE | |
| EA200101101A1 (en) | NEW PHARMACEUTICAL PREPARATION | |
| EA200101102A1 (en) | NEW PHARMACEUTICAL PREPARATION | |
| ECSP982779A (en) | A HYDRATE OF MALEIC ACID SALT, PROCESS FOR PREPARATION, PHARMACEUTICAL COMPOSITION AND ITS USE IN MEDICINE | |
| ECSP982781A (en) | 5- [4- (-N -METIL-N- (2-PIRIDIL) AMINO) ETOXI) BENSIL) THIAZOLIDINE - 2,4 DIONA MALEIC SALT HYDRATE | |
| ECSP003438A (en) | NEW COMPOUNDS | |
| AR017867A1 (en) | A HYDRAULATE OF THE MALEIC ACID SALT OF 5-4-2- (N-METHYL-N (2-PIRIDIL) AMINO) ETOXI BENCIL TIAZOLIDIN-2,4-DIONA, A PROCESS FOR ITS PREPARATION, A PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND THE USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT. | |
| ECSP003436A (en) | NEW COMPOUNDS | |
| ECSP003434A (en) | NEW COMPOUNDS | |
| TH84544A (en) | New type of hydration | |
| ECSP003437A (en) | NEW COMPOUNDS | |
| ECSP982457A (en) | NEW PHARMACEUTICAL PRODUCT | |
| TH84544B (en) | New type of hydration |